Cargando…
Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong
OBJECTIVE: To describe the infection control preparedness measures undertaken for coronavirus disease (COVID-19) due to SARS-CoV-2 (previously known as 2019 novel coronavirus) in the first 42 days after announcement of a cluster of pneumonia in China, on December 31, 2019 (day 1) in Hong Kong. METHO...
Autores principales: | Cheng, Vincent C. C., Wong, Shuk-Ching, Chen, Jonathan H. K., Yip, Cyril C. Y., Chuang, Vivien W. M., Tsang, Owen T. Y., Sridhar, Siddharth, Chan, Jasper F. W., Ho, Pak-Leung, Yuen, Kwok-Yung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137535/ https://www.ncbi.nlm.nih.gov/pubmed/32131908 http://dx.doi.org/10.1017/ice.2020.58 |
Ejemplares similares
-
Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
por: Cheng, Vincent C.C., et al.
Publicado: (2020) -
Japanese Encephalitis Virus Transmitted Via Blood Transfusion, Hong Kong, China
por: Cheng, Vincent C.C., et al.
Publicado: (2018) -
Recombinant Coxsackievirus A2 and Deaths of Children, Hong Kong, 2012
por: Yip, Cyril C.Y., et al.
Publicado: (2013) -
Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
por: Sridhar, Siddharth, et al.
Publicado: (2019) -
First Report of a Fatal Case Associated with EV-D68 Infection in Hong Kong and Emergence of an Interclade Recombinant in China Revealed by Genome Analysis
por: Yip, Cyril C. Y., et al.
Publicado: (2017)